Related Experiment Videos

[Immune-enhancing diet (IED) for acute respiratory distress syndrome]

T Sasaki1, T Nakagawa, N Oyama

  • 1Department of Thoracic Surgery, Senboku Kumiai General Hospital, Daisen, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|August 13, 2009
PubMed

Insights

This case study highlights how an immune-enhancing diet (IED) may improve outcomes for patients with acute respiratory distress syndrome (ARDS). Early enteral nutrition with IEDs shows promise in critical care settings.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Nutritional Science

Background:

  • Severe trauma can lead to acute respiratory distress syndrome (ARDS).
  • Management of ARDS often involves supportive care and nutritional strategies.
  • The role of specialized diets in ARDS recovery requires further investigation.

Purpose of the Study:

  • To report a case of ARDS following severe trauma.
  • To evaluate the efficacy of an immune-enhancing diet (IED) in a patient with ARDS.
  • To explore potential benefits of early enteral nutrition in critical care.

Main Methods:

  • A 63-year-old male with flail chest and hemopneumothorax received endotracheal intubation and chest tube insertion.
  • Standard medical treatments including sivelestat sodium hydrate and methylprednisolone were administered.
  • Enteral nutrition with an immune-enhancing diet (IED, Oxepa) was initiated.

Main Results:

  • Initial treatments were ineffective in improving oxygenation.
  • The PaO2/FiO2 ratio showed rapid improvement after starting the immune-enhancing diet.
  • The patient was successfully extubated on hospital day 34.

Conclusions:

  • This case suggests that an immune-enhancing diet may be a beneficial adjunctive therapy for ARDS.
  • Early enteral nutrition with specialized diets warrants consideration in managing critical care patients with respiratory failure.
  • Further research is needed to confirm the efficacy of IEDs in ARDS treatment.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...